Patents Assigned to Biomedical, Inc.
  • Patent number: 12290667
    Abstract: A monitoring feature, such as, for example, a pen cap, for an insulin delivery device may include at least one circuit adapted to detect at least one of a capping or decapping of the pen cap from an insulin pen and a processor for using information to the at least one of a capping or decapping of the pen cap. A monitoring feature for an insulin delivery device includes at least one circuit adapted to detect use of the insulin delivery device.
    Type: Grant
    Filed: June 14, 2022
    Date of Patent: May 6, 2025
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Lane Desborough, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak
  • Patent number: 12281927
    Abstract: Embodiments described herein generally relate to devices, systems and methods for measuring the dose remaining in a drug delivery device that is used for delivering a dose to a patient. In some embodiments, a dose measurement system for measuring the liquid volume in a container includes a plurality of light sources which are disposed and configured to emit electromagnetic radiation toward the container. A plurality of sensors are located in the apparatus that are optically coupleable to the plurality of light sources and are disposed and configured to detect the electromagnetic radiation emitted by at least a portion of the light sources. The apparatus also includes a processing unit configured to receive data representing the portion of the detected electromagnetic radiation from each of the plurality of sensors. The processing unit is further operable to convert the received data into a signature representative of the electromagnetic radiation detected by the plurality of sensors.
    Type: Grant
    Filed: June 3, 2024
    Date of Patent: April 22, 2025
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Richard Whalley, James White
  • Patent number: 12283357
    Abstract: A personal diabetes equipment management system can include at least one diabetes treatment device adapted for use with one or more disposable diabetes devices; a remote server system including an inventory database identifying operational diabetes treatment devices and operational disposable diabetes devices in the possession of a user; and a controller in communication with (i) the at least one diabetes treatment device over a first network connection and (ii) the remote server system over a second network connection, the controller adapted to automatically detect use of the at least one diabetes treatment device and determine an operational condition for the diabetes treatment device or the one or more disposable diabetes treatment devices based on information received from the at least one diabetes treatment device over the first network connection, the controller transmitting update information to the remote server system over the second network connection to update the inventory database.
    Type: Grant
    Filed: January 5, 2022
    Date of Patent: April 22, 2025
    Assignee: BIIGFOOT BIOMEDICAL, INC.
    Inventors: Jeffrey Brewer, Jon Brilliant
  • Patent number: 12268770
    Abstract: Disclosed herein are compositions comprising complexes of cyclodextrins and lipid-modified stem cell proteins. Also disclosed are topical compositions the complexes. Methods of using the compositions for the therapeutic purposes are also disclosed as well as methods of producing the compositions.
    Type: Grant
    Filed: April 26, 2023
    Date of Patent: April 8, 2025
    Assignee: AiVita Biomedical, Inc.
    Inventor: Gabriel Nistor
  • Patent number: 12268518
    Abstract: Medical radar devices, including ultra-wideband (UWB) devices, for use in assisting and/or guiding cardiopulmonary resuscitation (CPR) by indicating one or more of: compression depth, compression frequency, and a return to spontaneous circulation. The devices and methods described herein may use reflected energy applied to a patient's chest to determine cardiac motion and/or chest compression and provide feedback to the person applying the CPR. In some variations the device is incorporated as a part of another resuscitation device, such as a defibrillator or automatic compression device.
    Type: Grant
    Filed: June 18, 2021
    Date of Patent: April 8, 2025
    Assignee: Lifewave Biomedical, Inc.
    Inventor: Joe Paul Tupin, Jr.
  • Publication number: 20250099223
    Abstract: A vascular access device and assembly characterized by a tubular access graft having at least one angled distal flange that forms a non-circular distal opening to the tubular access graft, with the angled distal flange having a reinforcement structure that expands the flange and abuts a luminal wall surface of a blood vessel. Optionally, an axial compression ring or cuff may be provided that concentrically engages the tubular access graft and is translatable into a position that abuts an abluminal wall surface of the blood vessel. Also optionally, the device and assembly may include an annular ring with a plurality of axially projecting tines arrayed about a circumference of the annular ring, the annular ring being adapted to evert upon engagement with vascular tissue and creation of an access open by either an arteriotomy or a venotomy. The plurality of tines are configured to engage vascular tissue and then rotate to a different axial orientation to evert the periphery of the access site.
    Type: Application
    Filed: September 19, 2024
    Publication date: March 27, 2025
    Applicants: Connex Biomedical, Inc., The Board of Regents of University of Colorado, a body corporate
    Inventors: Max Bannister Mitchell, Jeremy H. Morgan, Jeffrey N. Steinmetz
  • Publication number: 20250090809
    Abstract: A steering device and navigation system for interventional procedures. Included are devices, systems, and methods that incorporate a steering device which consists of an expandable structure that can be controlled to spread out within the vessel lumen, or cardiac chamber, and may apply circumferential force to the tissue. This structure, once spread out, can anchor relative to the anatomy and provides support for an internal catheter through a set of strings connected to the internal catheter. The internal catheter is configured to allow an interventional device, such as a guidewire or catheter, to pass through it. Using the strings that are connected to actuation mechanisms within the device's handle, the internal catheter can be manipulated to allow 10 controlling the position of a device that runs within it or is connected to it and can be used for the purpose of navigation of devices and obtaining measurements from known positions.
    Type: Application
    Filed: November 27, 2024
    Publication date: March 20, 2025
    Applicant: MAGELLAN BIOMEDICAL INC.
    Inventors: Mohammad Ali TAVALLAEI, Emily Man-Sheun LAM, James Jiewen ZHOU, Graham A. Wright
  • Publication number: 20250082451
    Abstract: An oral appliance and a method of making the oral appliance for delivering a medicament to an oral cavity are provided. The method comprises forming a non-porous material into a portion of the oral appliance; and applying a porous material to one or more discrete regions of the portion of the oral appliance to make the one or more discrete regions of the oral appliance porous thereby forming the oral appliance.
    Type: Application
    Filed: November 26, 2024
    Publication date: March 13, 2025
    Applicant: Emanate Biomedical, Inc.
    Inventor: Peter John Zegarelli
  • Patent number: 12239703
    Abstract: The present invention discloses a composite-type nano-vaccine particle, which comprises an active ingredient selected from spike RBD protein of COVID-19, two adjuvants as aluminium salt nanoparticle and synthetic oligonucleotides, and an amphiphilic alginate-based nanocarrier encapsulating the active ingredient and the two adjuvants. The composite-type nano-vaccine particle has a particle size ranging from 300 nm to 1400 nm in diameter.
    Type: Grant
    Filed: May 11, 2022
    Date of Patent: March 4, 2025
    Assignee: Nuecology Biomedical Inc.
    Inventors: Chung Chin Sun, Dean Mo Liu
  • Patent number: 12239429
    Abstract: An apparatus and method for non-invasive and continuous measurement of respiratory chamber volume and associated parameters including respiratory rate, respiratory rhythm, tidal volume, dielectric variability and respiratory congestion. In particular, a non-invasive apparatus and method for determining dynamic and structural physiologic data from a living subject including a change in the spatial configuration of a respiratory chamber, a lung or a lobe of a lung to determine overall respiratory health comprising an ultra wide-band radar system having at least one transmitting and receiving antenna for applying ultra wide-band radio signals to a target area of the subject's anatomy wherein the receiving antenna collects and transmits signal returns from the target area.
    Type: Grant
    Filed: January 17, 2023
    Date of Patent: March 4, 2025
    Assignee: Livewave Biomedical, Inc.
    Inventors: Joe P. Tupin, Jr., Joe Paul Tupin, Kenneth Arlan Murray, Jr., John David Tupin
  • Publication number: 20250049989
    Abstract: Devices and methods for treatment of a tunnel wound in a mammal are disclosed. A device can include a suture, a tunnel filler, and a cap member. The suture can be folded to form a proximal loop and two distal ends. The tunnel filler can be compressed onto the suture between the proximal loop and the two distal ends. And the cap member can be positioned on the suture distal to the tunnel filler. The tunnel filler can comprise decellularized mammalian extracellular matrix. The device can further include a tamp member positioned over the suture distal to the cap member. A method of treating a tunnel wound can include introducing the device into the tunnel wound, applying pressure to an end of the tunnel filler by sliding the tamp member along the suture, removing the tamp member from the suture, and securing an end of the suture to an end of the tunnel wound.
    Type: Application
    Filed: May 31, 2023
    Publication date: February 13, 2025
    Applicant: Reprise Biomedical, Inc.
    Inventors: Jason Isenburg, Kyle Bettinger
  • Publication number: 20250041598
    Abstract: In an illustrative embodiment, methods and system for increasing coagulation potential and/or triggering a higher platelet activation rate in a subject via auricular neurostimulation include contacting skin of the subject with one or more therapeutic electrodes, each electrode positioned in a respective region of nerve structures of the auriculotemporal nerve (ATN), nerve structures connected to the ATN, nerve structures of the auricular branch of the vagus nerve (ABVN), or nerve structures connected to the ABVN, applying, to the electrodes, one or more stimulation patterns.
    Type: Application
    Filed: October 25, 2024
    Publication date: February 6, 2025
    Applicant: Spark Biomedical, Inc.
    Inventors: Alejandro Covalin, Christopher Czura, Navid Khodaparast
  • Patent number: 12214193
    Abstract: In an illustrative embodiment, systems and methods for inhibiting, reducing or eliminating motion sickness using a neuromodulation device configured to be worn on a subject's head and a controller configured to deliver therapeutic stimulation pulses for providing motion sickness therapy involve delivering, by the controller, a first series of stimulation pulses to first electrode(s) positioned on or near the subject's ear in a first tissue region to modulate peripheral activity, and delivering, by the controller, a second series of stimulation pulses to second electrode(s) positioned on or near the subject's ear in a second tissue region t to modulate one or more areas in the subject's brain stem.
    Type: Grant
    Filed: April 8, 2024
    Date of Patent: February 4, 2025
    Assignee: SPARK BIOMEDICAL, INC.
    Inventors: Alejandro Covalin, Navid Khodaparast, Melanie McWade
  • Publication number: 20250032671
    Abstract: An inflated and suspension dried decellularized extracellular matrix of a mammalian organ or tissue, or a vascularized portion thereof, and methods of making and using the inflated and suspension dried material, are provided.
    Type: Application
    Filed: October 7, 2024
    Publication date: January 30, 2025
    Applicant: Reprise Biomedical, Inc.
    Inventor: Jason Isenburg
  • Patent number: 12208251
    Abstract: One or more embodiments of the disclosure relate, generally, to a replacement pen cap for a medication injection pen comprising at least one temperature sensor for monitoring a temperature of a medication, detect dosing events, and determine that medication may be denatured based on temperature data, received analyte measurement data prior, and the detected dosing events.
    Type: Grant
    Filed: December 13, 2021
    Date of Patent: January 28, 2025
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 12207984
    Abstract: An oral appliance is provided for delivering a medicament to at least a portion of teeth and/or soft tissue areas inside a mouth. The oral appliance contains an interior surface having a medicament disposed in or on at least a portion of and/or the entire interior surface of the oral appliance. The interior surface of the oral cavity is formed to fit contours of at least the portion of the teeth and/or soft tissue areas inside the oral cavity and is configured for holding the medicament in contact with at least the portion of the teeth and/or soft tissue areas inside the oral cavity to deliver the medicament to strategic areas in need of treatment. In some embodiments, computer, network and computer readable storage media are provided.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: January 28, 2025
    Assignee: Emanate Biomedical, Inc.
    Inventor: Peter John Zegarelli
  • Patent number: 12205699
    Abstract: Systems, methods and devices are described for establishing trusted connections among two or more therapy devices that form, or form part of, a medication therapy system. A medication delivery electronics may include a first communication interface, a connection manager, and a therapy management application. A first communication interface may be configured to establish and communicate over one or more communication links. A connection manager may be configured to generate a candidate shared secret key and provide the shared key to a first therapy device over a first communication link established by a first communication interface. A candidate shared key may be generated responsive to one or more shared secret parameters.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: January 21, 2025
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Aaron Kim, Bryan Mazlish
  • Patent number: 12201558
    Abstract: An apparatus includes a housing coupled to a medicament container, which is coupled to a needle. An injection assembly is disposed within the housing and includes an energy storage member and an actuation rod. A distal end portion of the actuation rod is disposed within the medicament container. The energy storage member can produce a force on a proximal end portion of the actuation rod sufficient to move the distal end portion of the actuation rod within the medicament container. This can convey at least a portion of a substance from the medicament container via the needle when a distal tip of the needle is disposed within a first region of a target location. The force is insufficient to move the distal end portion of the actuation rod within the medicament container when the distal tip of the needle is disposed within a second region of the target location.
    Type: Grant
    Filed: January 19, 2023
    Date of Patent: January 21, 2025
    Assignee: Clearside Biomedical, Inc.
    Inventors: Rafael Victor Andino, Vladimir Zarnitsyn, Jesse Yoo, Christopher John Brooks, Trent John Kahute, Justin William Arsenault, David Jackson Trettin, Andrew Kent Bauer, Stephanie Elaine Lewis
  • Patent number: 12194251
    Abstract: A steering device and navigation system for interventional procedures. Included are devices, systems, and methods that incorporate a steering device which consists of an expandable structure that can be controlled to spread out within the vessel lumen, or cardiac chamber, and may apply circumferential force to the tissue. This structure, once spread out, can anchor relative to the anatomy and provides support for an internal catheter through a set of strings connected to the internal catheter. The internal catheter is configured to allow an interventional device, such as a guidewire or catheter, to pass through it. Using the strings that are connected to actuation mechanisms within the device's handle, the internal catheter can be manipulated to allow controlling the position of a device that runs within it or is connected to it and can be used for the purpose of navigation of devices and obtaining measurements from known positions.
    Type: Grant
    Filed: May 1, 2019
    Date of Patent: January 14, 2025
    Assignee: MAGELLAN BIOMEDICAL INC.
    Inventors: Mohammad Ali Tavallaei, Emily Man-Sheun Lam, James Jiewen Zhou, Graham A. Wright
  • Patent number: D1058631
    Type: Grant
    Filed: April 7, 2023
    Date of Patent: January 21, 2025
    Assignee: Globe Biomedical, Inc.
    Inventor: Joshua Park